Complete Up To Date Information about Aureomycin Soluble Oblets.
NADA Number: 055-039 | |
| Proprietary Name |
Aureomycin® Soluble Oblets |
|---|---|
| Sponsor |
Fort Dodge Animal Health, Division of Wyeth Holdings Corp. |
| Sponsor Address |
P. O. Box 1339 Fort Dodge, IA 50501 USA |
| Ingredients |
Chlortetracycline Hydrochloride |
| Species |
Cattle, calves |
| Routes of Administration |
Per Os |
| Dose Form |
Bolus Liquid (solution) |
| Drug Form |
Bolus |
| Dispensing Status |
OTC |
| Withdrawal Time |
|
|
Dosage Amount, Indications & Limitations |
520.445c Chlortetracycline tablets and boluses. Specifications: Each tablet/bolus contains 25 or 500 milligrams of chlortetracycline hydrochloride. Conditions of use: Cattle (calves) Amount: One 25 milligram tablet for each 5 pounds of body weight every 12 hours daily for 3 to 5 days. Indications: Control and treatment of bacterial enteritis (scours) caused by E. coli and Salmonella species and bacterial pneumonia associated with Pasteurella species, Hemophilus species, and Klebsiella species, susceptible to chlortetracycline. Limitations: Administer tablet directly by mouth or crush and dissolve in water for drenching. If no improvement is noted after 3 days of treatment, consult a veterinarian. Do not use for more than 5 days. When feeding milk or milk replacer, administration 1 hour before or 2 hours after feeding. Do not administer within 24 hours of slaughter. Amount: One 500 milligram bolus per 100 pounds of body weight twice a day for 3 to 5 days. Indications: Treatment of bacterial enteritis (scours) caused by E. coli and Salmonella species, and bacterial pneumonia associated with Pasteurella species, Hemophilus species, and Klebsiella species, susceptible to chlortetracycline. Limitations: Administer directly by mouth or crush and dissolve in water for drenching. If no improvement is noted after 3 days of treatment, consult a veterinarian. Do not use for more than 5 days. Do not administer within 24 hours of slaughter. NAS/NRC status: National Academy of Sciences/National Research Council NAS/NRC) status. The conditions of use specified in this section were NAS/NRC reviewed and found effective. Applications for these uses need not include effectiveness data as specified in Sec. 514.111 of this chapter but may require bioequivalency and safety information. |
| Tolerances |
Tolerances are established for the sum of tetracycline residues in tissues of beef cattle, nonlactating dairy cows, calves, swine, sheep, chickens, turkeys, and duck or 2 parts per million in muscle, 6 parts per million in liver, and 12 parts per million in fat and kidney. A tolerance is established for residues of chlortetracycline in eggs of 0.4 part per million. |